Orthofix Medical Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Orthofix Medical Inc. (OFIX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $41.59 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-26
- Orthofix Medical Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $27.23M.
- Orthofix Medical Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $9.60M, a 51.29% increase year-over-year.
- Orthofix Medical Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $2.68M, a 321.07% increase year-over-year.
- Orthofix Medical Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $2.08M.
- Orthofix Medical Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $41.59M.
- Orthofix Medical Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$24.09M, a 189.73% decline from fiscal 2015.
- Orthofix Medical Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $26.85M, a 240.24% increase from fiscal 2014.
- Orthofix Medical Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $7.89M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $27.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $36.83M derived: sum of 2 quarters · filed 2018-02-26 | $39.51M derived: sum of 3 quarters · filed 2018-02-26 | $41.59M 10-K · filed 2018-02-26 | |
| 2017-09-30 | $9.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $12.27M derived: sum of 2 quarters · filed 2017-10-30 | $14.35M 10-Q · filed 2017-10-30 | $7.10M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2017-06-30 | $2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $4.76M 10-Q · filed 2017-08-07 | -$2.49M derived: sum of 3 quarters · filed 2018-02-26 | $3.85M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2017-03-31 | $2.08M 10-Q · filed 2017-05-04 | -$5.17M derived: sum of 2 quarters · filed 2018-02-26 | $1.17M derived: sum of 3 quarters · filed 2018-02-26 | $1.81M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-12-31 | -$7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$910.00K derived: sum of 2 quarters · filed 2018-02-26 | -$274.00K derived: sum of 3 quarters · filed 2018-02-26 | -$24.09M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $6.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $6.98M derived: sum of 2 quarters · filed 2017-10-30 | -$16.84M 10-Q · filed 2017-10-30 | -$16.87M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-06-30 | $636.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$23.18M 10-Q · filed 2017-08-07 | -$23.21M derived: sum of 3 quarters · filed 2018-02-26 | -$15.46M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-03-31 | -$23.82M 10-Q · filed 2017-05-04 | -$23.85M derived: sum of 2 quarters · filed 2018-02-26 | -$16.10M derived: sum of 3 quarters · filed 2018-02-26 | $10.06M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2015-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $7.72M derived: sum of 2 quarters · filed 2018-02-26 | $33.88M derived: sum of 3 quarters · filed 2018-02-26 | $26.85M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $7.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $33.91M derived: sum of 2 quarters · filed 2016-10-31 | $26.88M 10-Q · filed 2016-10-31 | $33.87M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-30 | $26.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $19.13M 10-Q · filed 2016-08-01 | $26.12M derived: sum of 3 quarters · filed 2017-02-27 | $27.03M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-31 | -$7.03M 10-Q · filed 2016-04-28 | -$41.00K derived: sum of 2 quarters · filed 2017-02-27 | $865.00K derived: sum of 3 quarters · filed 2017-02-27 | $4.67M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2014-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $7.90M derived: sum of 2 quarters · filed 2017-02-27 | $11.70M derived: sum of 3 quarters · filed 2017-02-27 | $7.89M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $906.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $4.71M derived: sum of 2 quarters · filed 2015-11-03 | $901.00K 10-Q · filed 2015-11-03 | $9.10M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$5.00K 10-Q · filed 2015-08-04 | $8.19M derived: sum of 3 quarters · filed 2016-02-29 | $2.55M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$3.81M 10-Q · filed 2015-05-18 | $4.39M derived: sum of 2 quarters · filed 2016-02-29 | -$1.25M derived: sum of 3 quarters · filed 2016-02-29 | -$7.76M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.56M derived: sum of 2 quarters · filed 2016-02-29 | -$3.95M derived: sum of 3 quarters · filed 2016-02-29 | -$1.84M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$5.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-31 | -$12.14M derived: sum of 2 quarters · filed 2015-03-31 | -$10.04M 10-Q · filed 2015-03-31 | ||
| 2013-06-30 | -$6.50M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-03-31 | -$4.40M 10-Q · filed 2015-03-31 | |||
| 2013-03-31 | $2.11M 10-Q/A · filed 2015-03-31 | ||||
| 2012-12-31 | -$1.98M 10-K/A · filed 2015-03-31 | ||||
| 2011-12-31 | $3.72M derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | $5.26M derived: sum of 2 quarters · filed 2015-03-31 | $19.18M 10-K/A · filed 2015-03-31 | $19.65M 10-K · filed 2012-02-29 | |
| 2011-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $15.46M 10-Q · filed 2011-10-31 | |||
| 2011-06-30 | $13.92M 10-Q · filed 2011-08-05 | ||||
| 2010-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$6.13M derived: sum of 2 quarters · filed 2012-02-29 | $233.00K 10-K · filed 2012-02-29 | ||
| 2010-09-30 | -$4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $1.92M 10-Q · filed 2011-10-31 | |||
| 2010-06-30 | $6.37M 10-Q · filed 2011-08-05 | ||||
| 2009-12-31 | -$1.27M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |